Key statistics
On Tuesday, Novocure Ltd (NVCR:NSQ) closed at 11.13, 13.34% above the 52 week low of 9.82 set on Feb 09, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.14 |
|---|---|
| High | 11.36 |
| Low | 10.69 |
| Bid | 10.95 |
| Offer | 11.30 |
| Previous close | 10.99 |
| Average volume | 3.84m |
|---|---|
| Shares outstanding | 111.98m |
| Free float | 100.99m |
| P/E (TTM) | -- |
| Market cap | 1.23bn USD |
| EPS (TTM) | -1.61 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Press releases
- U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
- Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
- Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
- Novocure Appoints Company President Frank Leonard as Chief Executive Officer
- Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
More ▼
